Loading clinical trials...
Loading clinical trials...
SME3110 (Fluvoxamine Maleate) in the Treatment of Depression/Depressive State : A Post-marketing Clinical Study in Children and Adolescents (8 Through 18 Years of Age) -A Double-blind, Randomized, Placeb-controlled Study
Conditions
Interventions
Fluvoxamine maleate
Placebo
Locations
25
Japan
S114.3.117 Kohnodai Hospital, National Center of N
Chiba Prefecture, Japan
S114.3.117 Fukuoka University Hospital
Fukuoka Prefecture, Japan
S114.3.117 Hatakeyama Clinic
Fukuoka Prefecture, Japan
S114.3.117 Kaname Clinic
Fukuoka Prefecture, Japan
S114.3.117 Kashi shinryo Clinic
Fukuoka Prefecture, Japan
S114.3.117 Kashii Sanatorium
Fukuoka Prefecture, Japan
Start Date
October 1, 2006
Primary Completion Date
July 1, 2009
Completion Date
July 1, 2009
Last Updated
March 4, 2010
NCT07115329
NCT06793397
NCT07025720
NCT06780917
NCT04480918
NCT07329621
Lead Sponsor
Solvay Pharmaceuticals
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions